Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial

dc.contributor.authorTopkan, Erkan
dc.contributor.authorSomay, Efsun
dc.contributor.authorSelek, Ugur
dc.contributor.authorPehlivan, Berrin
dc.date.accessioned2025-12-23T07:20:05Z
dc.date.issued2024-03-29
dc.identifier.citationEUROPEAN JOURNAL OF CANCER, cilt 200, 2024en
dc.identifier.issn0959-8049
dc.identifier.urihttps://hdl.handle.net/11727/14221
dc.identifier.volume200en
dc.identifier.wos001188825600001en
dc.language.isoen_US
dc.publisherBaşkent Üniversitesi Diş Hekimliği Fakültesi
dc.sourceEUROPEAN JOURNAL OF CANCERen
dc.subjectHEAD
dc.title Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
dc.typeLetter

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Kapalı Erişim.pdf
Size:
78 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: